Please login to the form below

Not currently logged in
Email:
Password:

translational research

This page shows the latest translational research news and features for those working in and with pharma, biotech and healthcare.

Ferring agrees Chinese reproductive medicine research deal

Ferring agrees Chinese reproductive medicine research deal

Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) are set to collaborate on a long-term project to advance basic and translational research in reproductive medicine. ... Professor Hongemi Wang, director of the state key laboratory, CAS,

Latest news

  • Novartis and Bayer among backers for European big data project Novartis and Bayer among backers for European big data project

    A European project to advance big data-driven cardiovascular research has launched with EU and pharma backing. ... To do this the IMI consortium will develop a data-driven translational research platform to deliver clinically relevant disease phenotypes,

  • ICON boosts leadership teams ICON boosts leadership teams

    He has over 30 years of experience in pharmaceutical and contract research organisation (CRO) roles, joining from Quintiles where he led its global clinical analysis and reporting services group. ... Most recently, Dr McCracken led the Imaging Centre of

  • Medical Research Council launches disease compounds research library Medical Research Council launches disease compounds research library

    Medical Research Council launches disease compounds research library. Teams up with AZ, GSK, Janssen, Pfizer, Takeda and UCB. ... Commenting on the research library partnership, MRC's director of translational research and industry Dr Chris Watkins said:

  • Dr Robert Califf confirmed as new head of the FDA Dr Robert Califf confirmed as new head of the FDA

    Prior to joining the FDA in January 2015 Dr Califf was vice chancellor of clinical and translational research at Duke University in North Carolina in the US. ... His previous roles at Duke include director of the Duke Translational Medicine Institute

  • FDA approves Merrimack's pancreatic cancer drug FDA approves Merrimack's pancreatic cancer drug

    The approval comes on the back of clinical trial research that showed an increased survival rate of nearly two months without decreasing the quality of life compared to other treatments. ... The study was conducted by researchers at HonorHealth Research

More from news
Approximately 5 fully matching, plus 61 partially matching documents found.

Latest Intelligence

  • The real-world data conundrum The real-world data conundrum

    Studies (including a review from my team in 2016 published in BMC Health Services Research) now show that evidence from real-world data is increasingly used to inform published guidelines and ... To address expectations and capitalise on the value of real

  • The reality of real-world evidence The reality of real-world evidence

    The rise of health technology assessment (HTA) globally puts significant emphasis on health economic and outcome research (HEOR) analysis and RWE provides critical inputs into this. ... To meet this demand organisations need to work together to enable or

  • Real-world evidence Real-world evidence

    An emerging solution is the use of routinely collected data or clinical databases, research outputs of which are often collectively called real-world evidence (RWE). ... To fully capitalise on the potential value of using RWE, researchers need to ensure

  • EATRIS and the new age of partnering EATRIS and the new age of partnering

    It gained elite European Research Infrastructure Consortium status from the European Union in 2013 and has just staged its second annual conference - Building Bridges in Translational Medicine - where international speakers hailed ... we reduce the

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    Prior to that in September 2012, Novo Nordisk invested $100m in expanding its diabetes research facilities in Beijing. ... a translational science centre specialising in cancer research.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • Adjusting to change in healthcare: Learning from translational research

    Translational research organisations are responding by adjusting their strategies to align with the NHS, to contribute to delivering better patient outcomes, faster. ... Traditionally, the role of translational research is to increase the volume of basic

  • Blue Latitude Health

    Adjusting to change in healthcare: Learning from translational research. ... In this article, Blue Latitude Health's Head of Insight, Martine Leroy, explores how pharma could learn from translational research organisations in adapting their approach to

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics